Mayo Clinic in Florida has received a grant from the National Institute of Neurological Disorders and Stroke (NIDS) to begin an innovative study that will provide hundreds of patients with amyotrophic lateral sclerosis (ALS) access to the experimental drug ibudilast over six months.
‘Redlining’ and Cancer Screening; Talzenna OK’d for mCRPC; Genomic Testing Misused
Banned more than 50 years ago, historical redlining — financial institutions’ practice of not approving loans to individuals who live in areas associated with poor